Publications Database

Ali G. et al. (2016)

Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

November, 26(9), pp. 784-791.

Read Abstract (New Window)

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2010)

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(5), pp. 415-422.

Read Abstract (New Window)

Aman M. G. et al. (2017)

Safety and efficacy of memantine in children with autism: Randomized, placebo-controlled study and open-label extension.

Journal of Child and Adolescent Psychopharmacology

June, 27(5), pp. 403-412.

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

Arnold L. E. et al.

A 1.5-year follow-up of parent training and atomoxetine for attention-deficit hyperactivity disorder symptoms and noncompliant-disruptive behavior in autism.

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)

Arnold L. E. et al. (2012)

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

22(3), pp. 198-205.

Read Abstract (New Window)

Bishop S. , Gahagan S. , Lord C. (2007)

Re-examining the core features of autism: a comparison of autism spectrum disorder and fetal alcohol spectrum disorder

Journal of Child and Adolescent Psychopharmacology

48(11), pp. 1111-1121

Read Abstract (New Window)

Blankenship K. et al. (2011)

Guanfacine, extended, release, two, patients, pervasive, developmental, disorders

Journal of Child and Adolescent Psychopharmacology

21(3), pp. 287-290

Bozkurt H. et al. (2012)

Risperidone-induced paroxysmal perceptual alteration in a child with autism.

Journal of Child and Adolescent Psychopharmacology

22(6), pp. 470-471.

Read Extract (New Window)

Brodkin E. (1997)

Clomipramine in adults with pervasive developmental disorders: a prospective open-label investigation.

Journal of Child and Adolescent Psychopharmacology

7(2), pp. 109-121

Read Abstract (New Window)

Buckley A. et al. (2011)

An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

21(4), pp. 353-357

Read Abstract (New Window) Read Full (New Window)

Cop E. , Oner P. , Oner O. (2011)

Risperidone and double incontinence in a child with autism.

Journal of Child and Adolescent Psychopharmacology

21(6), pp. 647-648

Read Full (New Window)

Coskun M. et al. (2009)

Effectiveness of mirtazapine in the treatment of inappropriate sexual behaviors in individuals with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

19(2), pp. :203-206

Read Abstract (New Window)

Coskun M. , Mukaddes N. M. (2008)

Mirtazapine treatment in a subject with autistic disorder and fetishism

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 206-209

Read Abstract (New Window)

Couturier J. . L. , Nicolson R. (1992)

A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

12(3), pp. 243-248

Read Abstract (New Window)

Davazno P. , King B. H. (1996)

Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.

Journal of Child and Adolescent Psychopharmacology

6(4), pp. 273-279

Read Abstract (New Window)

DiMartino A. et al. (2004)

Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.

Journal of Child and Adolescent Psychopharmacology

14(2), pp. 207-218

Read Abstract (New Window)

Erickson C. A. et al. (2011)

An open-label naturalistic pilot study of acamprosate in youth with autistic disorder

Journal of Child and Adolescent Psychopharmacology

Read Abstract (New Window)